Clinical Trial Update: Real-World Study of IL-23 Inhibitors in Active Crohn's Disease

View source ↗

Summary

A real-world study evaluating IL-23 inhibitors in patients with active Crohn's disease is currently recruiting at the Sixth Affiliated Hospital, Sun Yat-sen Uni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Guselkumab (guselkumab)
• Mirikizumab (mirikizumab)
• Risankizumab (risankizumab)

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Crohn's Disease | Status: RECRUITING